Key FDA Panel Discusses COVID-19 Boosters: What we Learned

The Food and Drug Administration's (FDA) vaccine advisory panel met Wednesday to discuss future COVID-19 booster doses and how to prepare for new strains of the coronavirus that may emerge.

No comments:

Post a Comment